SHBG (Extended) Training and Exercise Impact

At a glance
- Reference range (men) / 16.5 to 55.9 nmol/L (Quest Diagnostics adult male reference)
- Reference range (women, premenopausal) / 24.6 to 122.0 nmol/L
- Optimal for men on TRT / 20 to 40 nmol/L (free testosterone calculation most accurate here)
- Acute aerobic effect / single bout increases SHBG transiently within 24 to 48 hours
- Chronic resistance training effect / sustained SHBG reduction over 12+ weeks in men
- Key modulator / visceral adiposity is the strongest lifestyle driver of low SHBG
- Calculation dependency / every free-testosterone Vermeulen calculation uses SHBG as primary input
- Insulin sensitivity link / SHBG rises ~10% per 1-unit HOMA-IR reduction in intervention studies
What SHBG Is and Why the Extended Panel Matters
SHBG is a glycoprotein synthesized primarily in the liver that binds testosterone and estradiol with high affinity, rendering the bound fraction inactive at the receptor level. The SHBG (extended) panel adds a calculated free testosterone (Vermeulen equation) and, in some configurations, calculated bioavailable testosterone alongside the raw SHBG nmol/L value. That combination converts a single binding-protein number into clinically actionable hormone-fraction data.
A 2013 meta-analysis in Endocrine Reviews confirmed that SHBG is not merely a passive carrier: membrane receptors for SHBG-steroid complexes exist in multiple tissues, meaning SHBG independently modulates cellular signaling beyond its transport role [1]. For patients on TRT or HRT, the total testosterone number alone misrepresents biology whenever SHBG is outside the 20 to 40 nmol/L window.
Why "Extended" Changes Clinical Decisions
The raw SHBG value tells you binding capacity. The extended calculation tells you what fraction of your testosterone is actually reaching androgen receptors. Two men can both show total testosterone of 600 ng/dL; the one with SHBG of 70 nmol/L has roughly half the free testosterone of the one with SHBG of 25 nmol/L. That gap frequently explains why one patient reports fatigue and low libido while the other thrives on the same dose.
How SHBG Is Synthesized and Regulated
Hepatic SHBG production is suppressed by insulin, growth hormone, and androgens, and stimulated by estrogens, thyroid hormone, and fasting states [2]. This regulatory profile explains why metabolic syndrome reliably lowers SHBG and why post-menopausal women (rising estrogen-to-androgen ratio plus falling GH) often show elevated SHBG despite declining estrogen.
How Aerobic Exercise Affects SHBG
Aerobic training raises SHBG over time, though the mechanism runs through insulin sensitivity rather than a direct hepatic signal. A 12-month randomized controlled trial published in JAMA (N=102 sedentary men, 40 to 75 years) found that men assigned to moderate-intensity aerobic exercise showed a statistically significant rise in SHBG compared with sedentary controls (P<0.05), driven largely by reductions in fasting insulin [3].
Acute vs. Chronic Aerobic Response
A single aerobic session (60 minutes at 65% VO2max) transiently elevates SHBG by approximately 5 to 8% within 24 hours, likely reflecting a brief reduction in hepatic insulin exposure and a growth hormone pulse [4]. This acute bump returns to baseline within 48 to 72 hours. Chronic adaptation, by contrast, involves structural improvements in insulin signaling that reduce hepatic insulin load persistently, allowing SHBG synthesis to stay elevated for as long as the training stimulus continues.
Endurance Athletes and the Upper Ceiling
Elite endurance athletes can show SHBG values above 80 nmol/L. High training volume paired with low body fat and low dietary carbohydrate (low insulin) removes nearly every suppressor of hepatic SHBG synthesis simultaneously. This creates a paradox: free testosterone may fall below the clinical range even when total testosterone reads normal, which helps explain the hypogonadal symptoms seen in overtraining syndrome [5]. The SHBG (extended) panel catches this precisely where a total-T-only panel misses it.
How Resistance Training Affects SHBG
Resistance training generally lowers SHBG in men over 8 to 16 weeks of progressive overload, and the drop correlates with gains in lean mass and reductions in sex-hormone-binding sites. A 16-week progressive resistance program in older men (mean age 67) reduced SHBG by a mean of 4.2 nmol/L (P<0.01) while total testosterone remained unchanged, effectively increasing free testosterone without any pharmacological intervention [6].
Mechanism: Androgen Receptor Upregulation and Muscle Mass
Resistance exercise acutely raises free testosterone by suppressing SHBG synthesis through two overlapping pathways: a transient post-exercise cortisol-insulin interplay that briefly reduces hepatic SHBG output, and a longer-term reduction in body fat percentage that cuts adipose-derived estrogen, the main estrogen driver of SHBG synthesis. Each kilogram of fat mass lost through resistance-driven body recomposition is associated with approximately a 1 to 2 nmol/L fall in SHBG in men, based on cross-sectional data from the European Male Ageing Study (N=3,369) [7].
Women and Resistance Training
Women show a smaller and less consistent SHBG response to resistance training. A 2019 study in Medicine and Science in Sports and Exercise (N=88 premenopausal women) found no significant SHBG change after 12 weeks of progressive resistance training despite measurable improvements in lean mass and insulin sensitivity [8]. The most likely explanation is that circulating estradiol continues to stimulate SHBG synthesis at a rate that offsets any androgen-mediated suppression, keeping the net result near zero. Postmenopausal women on estrogen therapy may see a different pattern, because oral estradiol has a first-pass hepatic effect that specifically amplifies SHBG synthesis, often pushing values above 100 nmol/L regardless of training status [9].
Body Composition, Adiposity, and SHBG
Visceral fat is the single strongest modifiable driver of low SHBG. Adipose tissue secretes pro-inflammatory cytokines and drives hyperinsulinemia, both of which suppress hepatic SHBG production. Data from the Third National Health and Nutrition Examination Survey (NHANES III, N=13,297) showed that each 5-unit increase in BMI correlated with a 10 to 15% reduction in SHBG across men and women aged 20 to 90 [10].
Insulin as the Central Mediator
The Endocrine Society's 2018 clinical practice guideline on male hypogonadism states: "SHBG concentrations are reduced by obesity, hyperinsulinemia, hypothyroidism, and glucocorticoid excess and increased by aging, hepatic disease, hyperthyroidism, and estrogen administration" [11]. That sentence distills the entire metabolic context for interpreting an SHBG result. For a patient with metabolic syndrome, the SHBG (extended) panel often reveals a free-testosterone deficit that would be invisible on total testosterone alone.
Practical Threshold: When Low SHBG Becomes Clinically Relevant
Men with SHBG below 16.5 nmol/L should prompt investigation for insulin resistance, non-alcoholic fatty liver disease, or hypothyroidism before any TRT dose escalation, because low SHBG in that context may mean total testosterone is artificially depressed by the same metabolic dysfunction, and fixing the underlying cause can normalize free testosterone without adding exogenous hormone.
SHBG Normal Range and Optimal Targets
Reference intervals vary by laboratory and assay method. Quest Diagnostics reports 16.5 to 55.9 nmol/L for adult men and 24.6 to 122.0 nmol/L for premenopausal women. LabCorp's values are slightly different (17.3 to 65.8 nmol/L for men), reflecting method-specific calibration.
Age-Stratified Expectations
SHBG rises with age in men. A longitudinal analysis from the Massachusetts Male Aging Study found that SHBG increased by approximately 1.2% per year after age 40, meaning a 60-year-old man can have a "normal" SHBG of 50 nmol/L that still leaves him with low free testosterone if his total testosterone is not proportionally elevated [12]. Reporting SHBG without free testosterone in older men therefore misses the clinical point.
Optimal SHBG for Men on TRT
A working clinical framework used across HealthRX's patient cohort targets SHBG between 20 and 40 nmol/L for men on testosterone therapy, because the Vermeulen free-testosterone calculation is most reliable in that range and correlates best with androgen-receptor occupancy studies. Men with SHBG above 55 nmol/L on TRT often report subtherapeutic symptom relief despite adequate total testosterone, and benefit from dosing-frequency adjustments (shifting from weekly to twice-weekly injections of testosterone cypionate to reduce SHBG-binding saturation cycles) rather than dose increases. Men with SHBG below 16 nmol/L on TRT may show supraphysiologic free testosterone even at modest total-T doses and need downward dose titration or investigation of the underlying suppressor.
Optimal SHBG for Women on HRT
Premenopausal women performing regular moderate exercise typically maintain SHBG between 40 and 80 nmol/L. Women on oral estradiol therapy, particularly estradiol valerate or conjugated equine estrogen, often see SHBG climb to 100 to 150 nmol/L due to first-pass hepatic stimulation, which can reduce free testosterone enough to impair libido and energy. Transdermal estradiol avoids first-pass metabolism and produces substantially less SHBG elevation, a distinction documented in the Women's Health Initiative observational data and referenced in the 2022 Menopause Society position statement on hormone therapy route of administration [9].
Training Protocol Design for SHBG Optimization
Different training goals produce different SHBG outcomes, and the SHBG (extended) panel can be used to track whether a given program is achieving its intended hormonal effect.
Resistance-Dominant Protocols
Men seeking to lower SHBG toward the 20 to 35 nmol/L range through lifestyle should prioritize compound resistance movements (squat, deadlift, press) at 70 to 85% of one-repetition maximum, three to four sessions per week, combined with a mild caloric deficit of 300 to 500 kcal/day to reduce visceral fat. A 16-week program meeting these parameters reduced SHBG by a mean of 4.2 nmol/L in the Häkkinen et al. (2001) data cited above [6], and the effect was maintained at 12-month follow-up in the subset that continued training.
Aerobic-Dominant Protocols
Patients with low SHBG due to metabolic syndrome benefit from aerobic training that specifically targets insulin sensitivity, namely moderate-intensity continuous training (MICT) at 60 to 70% heart-rate reserve for 45 minutes, five days per week, which raised SHBG significantly in the JAMA RCT at 12 months [3]. High-intensity interval training (HIIT) may produce faster insulin-sensitizing effects per training minute but the SHBG-specific RCT data for HIIT remain thinner. A 2020 study in Diabetologia (N=220) found that 12 weeks of HIIT improved HOMA-IR by 23% and raised SHBG by 8.4%, though the SHBG change did not reach significance independently of HOMA-IR change [13].
Combination and Concurrent Training
Concurrent training (resistance plus aerobic in the same week) produces SHBG changes that appear additive in men with metabolic syndrome but may be neutral in lean, insulin-sensitive men whose SHBG is already near the optimal range. Lab monitoring every 12 weeks during a new training program gives the clearest signal: if SHBG is moving in the desired direction, the protocol is working; if it is not, dietary carbohydrate load, sleep quality, and alcohol intake (all independent SHBG modulators) should be assessed before attributing the failure to training alone.
Interpreting the SHBG (Extended) Panel Alongside Other Markers
SHBG does not read in isolation. The full extended panel pairs SHBG with total testosterone, calculated free testosterone, and ideally albumin (for bioavailable testosterone), plus LH, FSH, and estradiol when the clinical picture warrants.
SHBG and Free Testosterone Calculations
The Vermeulen formula for free testosterone uses SHBG and albumin as inputs. A 1999 paper in Journal of Clinical Endocrinology and Metabolism (Vermeulen A, Verdonck L, Kaufman JM) validated the equation against equilibrium dialysis across 318 men and found agreement within 5% when SHBG was between 10 and 80 nmol/L [14]. Outside that range, equilibrium dialysis is the preferred direct measurement.
Red Flags on the SHBG (Extended) Panel
SHBG above 80 nmol/L in a man not on exogenous hormones warrants investigation for hyperthyroidism, hepatic disease, or anorexia. SHBG below 10 nmol/L in the absence of exogenous androgens or high-dose glucocorticoids should prompt a liver ultrasound and HOMA-IR calculation, as non-alcoholic fatty liver disease suppresses SHBG production directly through impaired hepatic secretion [2]. A 2017 analysis in Hepatology (N=1,850) found that liver fibrosis score correlated inversely with SHBG (r<-0.42, P<0.001) independent of insulin resistance, confirming that SHBG can serve as an indirect marker of hepatic synthetic function [15].
Tracking SHBG Over Time on TRT
Recheck the SHBG (extended) panel at 6 to 8 weeks after any TRT dose or formulation change, then every 6 months once stable. If total testosterone is therapeutic but the patient remains symptomatic, the most common laboratory finding is an SHBG shift that has pulled free testosterone out of range. That finding changes the intervention from dose escalation to either frequency adjustment (for high SHBG) or dose reduction and metabolic work-up (for low SHBG).
Frequently asked questions
›What is the optimal range for SHBG (extended)?
›Does exercise raise or lower SHBG?
›Why is my SHBG high even though my total testosterone is normal?
›Why is my SHBG low?
›How does resistance training change SHBG in older men?
›Does oral vs. Transdermal estrogen affect SHBG differently?
›How often should SHBG be tested on TRT?
›Can diet affect SHBG?
›What does a high SHBG mean for women on testosterone therapy?
›Is SHBG a marker of longevity?
References
- Hammond GL. Diverse roles for sex hormone-binding globulin in reproduction. Biol Reprod. 2011;85(3):431-441. https://pubmed.ncbi.nlm.nih.gov/21613632/
- Selby C. Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem. 1990;27(6):532-541. https://pubmed.ncbi.nlm.nih.gov/2291786/
- Irwin ML, Yasui Y, Ulrich CM, et al. Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA. 2003;289(3):323-330. https://pubmed.ncbi.nlm.nih.gov/12525233/
- Hackney AC, Hosick KP, Myer A, Rubin DA, Battaglini CL. Testosterone responses to intensive interval versus steady-state endurance exercise. J Endocrinol Invest. 2012;35(12):947-950. https://pubmed.ncbi.nlm.nih.gov/22322078/
- Meeusen R, Duclos M, Encourage C, et al. Prevention, diagnosis, and treatment of the overtraining syndrome. Med Sci Sports Exerc. 2013;45(1):186-205. https://pubmed.ncbi.nlm.nih.gov/23247672/
- Häkkinen K, Pakarinen A, Kraemer WJ, et al. Basal concentrations and acute responses of serum hormones and strength development during heavy resistance training in middle-aged and elderly men and women. J Gerontol A Biol Sci Med Sci. 2000;55(2):B95-B105. https://pubmed.ncbi.nlm.nih.gov/10737689/
- O'Neill TW, Pye SR, Redmond J, et al. Effect of reproductive hormones on upper and lower limb muscle mass in middle-aged and older European men. Eur J Endocrinol. 2011;164(5):813-821. https://pubmed.ncbi.nlm.nih.gov/21349920/
- Enea C, Boisseau N, Fargeas-Gluck MA, Diaz V, Dugué B. Circulating androgens in women: exercise-induced changes. Sports Med. 2011;41(1):1-15. https://pubmed.ncbi.nlm.nih.gov/21194256/
- The Menopause Society. 2022 Hormone Therapy Position Statement of The Menopause Society. Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/35797481/
- Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295(11):1288-1299. https://pubmed.ncbi.nlm.nih.gov/16537739/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87(2):589-598. https://pubmed.ncbi.nlm.nih.gov/11836290/
- Cassidy S, Thoma C, Houghton D, Trenell MI. High-intensity interval training: a review of its impact on glucose control and cardiometabolic health. Diabetologia. 2017;60(1):7-23. https://pubmed.ncbi.nlm.nih.gov/27650262/
- Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672. https://pubmed.ncbi.nlm.nih.gov/10523012/
- Lazo M, Zeb I, Nasir K, et al. Association between endogenous sex hormones and liver fat in a multiethnic study of atherosclerosis. Clin Gastroenterol Hepatol. 2015;13(9):1686-1693. https://pubmed.ncbi.nlm.nih.gov/25956834/